home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Dosimetry in clinical trials

 
  September 18, 2024  
     
 
Xtalks, Online
2024-10-24


Imaging and therapeutic dosimetry in precision nuclear medicine

Dosimetry is a well-established approach for routine treatment planning in radiation therapy. The dose of radiation energy absorbed by targeted and surrounding tissue is one of the main parameters that determines the biologic effect of radiation. Therefore, the estimation of absorbed radiation serves as an essential tool for making radiation-based treatments less damaging to the heathy tissue.

The physical and pharmacokinetic interactions of radiopharmaceuticals in the body add complexity to the internal dosimetric process required for radionuclide treatments. Lesion- or organ-based dosimetry approaches can yield parameters that have been extensively studied, such as lesion dose-response correlation, dose-volume histogram and dose heterogeneity map findings. These capabilities allow dosimetric data to offer a more suitable correlation between biologic effect and clinical outcomes.

Register for this webinar today to understand the vital role of dosimetry in enhancing radiation-based treatments and minimizing damage to healthy tissue.

Keywords: Drug Development, Precision Medicine, Clinical Research, CRO, Oncology, Radiology, Therapeutic Areas, Radiotherapy, Radiopharmaceuticals, Oncology Drug Development, Dosimetry
 
 
Organized by: Xtalks
Invited Speakers: Edward Ashton, Sr. Director, Oncology Imaging, Medical Imaging & Cardiac Safety Solutions, ICON
Carley Hartings, Imaging Scientist 1, Medical Imaging & Cardiac Safety Solutions, ICON
 
Deadline for Abstracts: 2024-10-24
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.